http://www.pharmacyeurope.net/rss.asp Latest news from Pharmacy Europe en-gb Copyright Campden Publishing Limited 2009 Fri, 13 Nov 2009 01:57:25 EST 30 20 21 22 23 0 1 2 3 4 5 6 Saturday Sunday http://feedproxy.google.com/~r/PharmacyEurope/~3/XfCSbuOw-40/default.asp http://www.pharmacyeurope.net/default.asp?title=NovartislaunchesPrevacid24HRover%2Dthe%2Dcounter&page=article.display&article.id=19302 Novartis announced the availability of Prevacid 24HR over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn http://www.pharmacyeurope.net/default.asp?title=NovartislaunchesPrevacid24HRover%2Dthe%2Dcounter&page=article.display&article.id=19302 http://feedproxy.google.com/~r/PharmacyEurope/~3/F9yqkW60G1c/default.asp http://www.pharmacyeurope.net/default.asp?title=SwinefludetectionkitsetforEU&page=article.display&article.id=19305 A test that differentiates the H1N1 virus from two seasonal flu strains will soon be used in Europe http://www.pharmacyeurope.net/default.asp?title=SwinefludetectionkitsetforEU&page=article.display&article.id=19305 http://feedproxy.google.com/~r/PharmacyEurope/~3/MvdlsGQ14Yc/default.asp http://www.pharmacyeurope.net/default.asp?title=Researchinto%22biowarfare%22diseases&page=article.display&article.id=19307 A $4m federal grant has been given to researchers in US for development of antibiotics to tackle plague, anthrax and tularemia http://www.pharmacyeurope.net/default.asp?title=Researchinto%22biowarfare%22diseases&page=article.display&article.id=19307 http://feedproxy.google.com/~r/PharmacyEurope/~3/zKpAu6OhVrk/default.asp http://www.pharmacyeurope.net/default.asp?title=Talksoninternetdrugmarketing&page=article.display&article.id=19308 Regulators are taking their initial first steps towards policing the 'wild west' of medical information available online http://www.pharmacyeurope.net/default.asp?title=Talksoninternetdrugmarketing&page=article.display&article.id=19308 http://feedproxy.google.com/~r/PharmacyEurope/~3/_zKI0GHOM7o/default.asp http://www.pharmacyeurope.net/default.asp?title=Drug%22destroys%22lungcancertumours&page=article.display&article.id=19295 A form of inoperable lung cancer that kills most sufferers could be combated by a drug that destroys tumours http://www.pharmacyeurope.net/default.asp?title=Drug%22destroys%22lungcancertumours&page=article.display&article.id=19295 http://feedproxy.google.com/~r/PharmacyEurope/~3/P1CondYAT8Q/default.asp http://www.pharmacyeurope.net/default.asp?title=Statins%27reduceriskofgallstones%27&page=article.display&article.id=19292 The risk of developing gallstones is significantly reduced by long-term use of statins to control cholesterol http://www.pharmacyeurope.net/default.asp?title=Statins%27reduceriskofgallstones%27&page=article.display&article.id=19292 http://feedproxy.google.com/~r/PharmacyEurope/~3/uGvX-HuSCA0/default.asp http://www.pharmacyeurope.net/default.asp?title=Drug%22lowerscancerrecurrence%22&page=article.display&article.id=19288 Women likely to have an early recurrence of breast cancer can cut the chances of the disease returning by receiving a drug as part of their chemotherapy http://www.pharmacyeurope.net/default.asp?title=Drug%22lowerscancerrecurrence%22&page=article.display&article.id=19288 http://feedproxy.google.com/~r/PharmacyEurope/~3/ooAmwVG5CKg/default.asp http://www.pharmacyeurope.net/default.asp?title=Lundbeckupdate&page=article.display&article.id=19300 Announcement of transactions with shares and linked securities in Lundbeck made by executives and their closely associated persons and legal entities http://www.pharmacyeurope.net/default.asp?title=Lundbeckupdate&page=article.display&article.id=19300 http://feedproxy.google.com/~r/PharmacyEurope/~3/9ix4lVP8rSA/default.asp http://www.pharmacyeurope.net/default.asp?title=IsmailKolajoinsUCB&page=article.display&article.id=19261 Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines http://www.pharmacyeurope.net/default.asp?title=IsmailKolajoinsUCB&page=article.display&article.id=19261 http://feedproxy.google.com/~r/PharmacyEurope/~3/MoWRDtdv-ww/default.asp http://www.pharmacyeurope.net/default.asp?title=HealthMoTincreasingGPs%27workload&page=article.display&article.id=19260 Pharmacists who refer patients for treatment after vascular screening could be needlessly giving GPs extra work http://www.pharmacyeurope.net/default.asp?title=HealthMoTincreasingGPs%27workload&page=article.display&article.id=19260 http://feedproxy.google.com/~r/PharmacyEurope/~3/RY0u96Yhnpg/default.asp http://www.pharmacyeurope.net/default.asp?title=Hopesfornewbrain%2Ddamagedrug&page=article.display&article.id=19259 SPECT trial reportedly shows that zolpidem drug counteracts loss of cognitive and motor functions associated with brain damage http://www.pharmacyeurope.net/default.asp?title=Hopesfornewbrain%2Ddamagedrug&page=article.display&article.id=19259 http://feedproxy.google.com/~r/PharmacyEurope/~3/NOomrQSa-iA/default.asp http://www.pharmacyeurope.net/default.asp?title=Drugboostsbreast%2Dcancertreatment&page=article.display&article.id=19258 Although capecitabine added to chemotherapy for breast cancer improves survival rates, side-effects will force some patients to discontinue the treatment http://www.pharmacyeurope.net/default.asp?title=Drugboostsbreast%2Dcancertreatment&page=article.display&article.id=19258 http://feedproxy.google.com/~r/PharmacyEurope/~3/h9aspSIjIgs/default.asp http://www.pharmacyeurope.net/default.asp?title=Tysabrialertoverbraininfection&page=article.display&article.id=19246 Labelling of multiple sclerosis drug has been changed to point up the increased risk of contracting multifocal leukoencephalopathy http://www.pharmacyeurope.net/default.asp?title=Tysabrialertoverbraininfection&page=article.display&article.id=19246 http://feedproxy.google.com/~r/PharmacyEurope/~3/XL8uXIbIOKE/default.asp http://www.pharmacyeurope.net/default.asp?title=Drugregulatorpersonnelcriticised&page=article.display&article.id=19243 A quarter of senior personnel at Irish Medicines Board have been accused of having a "potential conflict of interest" in new report http://www.pharmacyeurope.net/default.asp?title=Drugregulatorpersonnelcriticised&page=article.display&article.id=19243 http://feedproxy.google.com/~r/PharmacyEurope/~3/lLJYNi3fwws/default.asp http://www.pharmacyeurope.net/default.asp?title=Cetuximab%22boostscancersurvival%22&page=article.display&article.id=19242 Adding cetuximab to radiation therapy should now be considered as a standard treatment option, according to a report in The Lancet Oncology http://www.pharmacyeurope.net/default.asp?title=Cetuximab%22boostscancersurvival%22&page=article.display&article.id=19242 http://feedproxy.google.com/~r/PharmacyEurope/~3/KZVZJ-g3dHM/default.asp http://www.pharmacyeurope.net/default.asp?title=NycomedwelcomesSMCdecisiononInstanyl&page=article.display&article.id=19281 Nycomed welcomes the decision by the Scottish Medicines Consortium (SMC) on Instanyl, the only fast-acting intranasal treatment licensed for breakthrough cancer pain http://www.pharmacyeurope.net/default.asp?title=NycomedwelcomesSMCdecisiononInstanyl&page=article.display&article.id=19281 http://feedproxy.google.com/~r/PharmacyEurope/~3/yR_aTyq21Ns/default.asp http://www.pharmacyeurope.net/default.asp?title=UCBExtraordinaryGeneralMeeting&page=article.display&article.id=19236 Meeting follows successful placement of senior unsecured convertible bonds, due in 2015 http://www.pharmacyeurope.net/default.asp?title=UCBExtraordinaryGeneralMeeting&page=article.display&article.id=19236 http://feedproxy.google.com/~r/PharmacyEurope/~3/REtw4_CrzyI/default.asp http://www.pharmacyeurope.net/default.asp?title=Drughopeforanaemiasufferers&page=article.display&article.id=19228 The effects of a rare but potent form of anaemia could be reduced after an experimental new drug successfully completed a UK trial http://www.pharmacyeurope.net/default.asp?title=Drughopeforanaemiasufferers&page=article.display&article.id=19228 http://feedproxy.google.com/~r/PharmacyEurope/~3/HHUsQ8DAydU/default.asp http://www.pharmacyeurope.net/default.asp?title=GlobalHealthAcademyprojectopens&page=article.display&article.id=19227 A health school has been launched in Scotland aimed at tackling two of the most common diseases in developing world http://www.pharmacyeurope.net/default.asp?title=GlobalHealthAcademyprojectopens&page=article.display&article.id=19227 http://feedproxy.google.com/~r/PharmacyEurope/~3/XGcjbJAAIGI/default.asp http://www.pharmacyeurope.net/default.asp?title=BiovitrumandSwedishOrphanwillbecombinedformingSwedishOrphanBiovitrum&page=article.display&article.id=19210 The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation and growth potential http://www.pharmacyeurope.net/default.asp?title=BiovitrumandSwedishOrphanwillbecombinedformingSwedishOrphanBiovitrum&page=article.display&article.id=19210